Overview

Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant

Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetic properties of rilpivirine and darunavir when used in combination with etonogestrel
Phase:
Phase 2
Details
Lead Sponsor:
Makerere University
Collaborators:
University of Liverpool
University of Nebraska
University of Pittsburgh
Treatments:
Darunavir
Desogestrel
Etonogestrel
Rilpivirine